Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer
- DOI
- 10.1097/cco.0000000000001270
- Published
- 2026-10-01
- Container
- Current Opinion in Oncology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/cco.0000000000001270,
title = {Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer},
author = {Rui Kitadai and Filipa Lynce and Ana C. Garrido-Castro},
year = {2026},
journal = {Current Opinion in Oncology},
doi = {10.1097/cco.0000000000001270},
url = {https://doi.org/10.1097/cco.0000000000001270}
}RIS
TY - JOUR TI - Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer AU - Rui Kitadai AU - Filipa Lynce AU - Ana C. Garrido-Castro PY - 2026 JO - Current Opinion in Oncology DO - 10.1097/cco.0000000000001270 UR - https://doi.org/10.1097/cco.0000000000001270 ER -
APA
Kitadai, R., Lynce, F., & Garrido-Castro, A. C. (2026). Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer. Current Opinion in Oncology. https://doi.org/10.1097/cco.0000000000001270
Source records
- crossref · retrieved 2026-11-10T20:44:48.185Z